Ongoing
CTN 272: Canadian HIV and Aging cohort
Determinants of Increased Risk of Cardiovascular Diseases in Individuals Living with HIV
Learn MoreOngoing
Determinants of Increased Risk of Cardiovascular Diseases in Individuals Living with HIV
Learn MoreReporting
A small group intervention to reduce HIV sexual transmission risk behaviour among HIV-positive men who have sex with men: Gay Positive Sex (GPS)
Learn MoreCompleted
On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
Learn MoreReporting
HIV prevention for gay and bisexual men via reduction of social anxiety and substance use in sexual situations
Learn MoreCompleted
Prospective investigation of the relationship between food insecurity and health and behavioural outcomes in HIV-HCV co-Infection: Clues for prevention interventions. A food security & HIV-HCV sub-study of the Canadian Co-Infection Cohort (CTN 222)
Learn MoreReporting
Canadian HIV women’s sexual and reproductive health cohort study
Learn MoreCompleted
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals.
Learn MoreCompleted
Impact of HIV infection and antiretroviral therapy on mucosal and systemic memory CD4 T cells
Learn MoreCompleted
A randomized, double blind, phase IIB study testing the efficacy and safety of AGS-004 on host control of HIV replication during analytical treatment interruption: Trial results
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.